{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:34:55Z","timestamp":1777588495742,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Endourology"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Lower urinary tract symptoms among adult men can significantly impact quality of life. We evaluated complications based on prostate size following plasmakinetic enucleation of the prostate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Patients were grouped into the small prostate group (SPG, &lt;75\u2009g) and large prostate group (LPG, &gt;75\u2009g) based on preoperative imaging. Patient data on demographics, comorbidities, preoperative international prostate symptom score (IPSS), bother index (BI), prostate-specific antigen (PSA) if indicated, postvoid residual volume (PVR), indwelling catheter or self-catheterization status, and any prior surgical intervention were evaluated. Postoperative IPSS, BI, and PVR values were assessed at 6 weeks, 4 months, and yearly. Postoperative urge urinary incontinence (UUI), stress urinary incontinence (SUI), and pad use were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Between September 2015 and December 2020, 296 patients who underwent bipolar enucleation with minimum follow-up of 4 months were evaluated. Postoperative IPSS, BI, PVR, and PSA values at all time points were significantly decreased compared with preoperative values (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05). There was no significant difference in the complications between groups. Univariable and multivariable analysis found that size &lt;75\u2009g was predictive of stricture formation and bladder neck contracture (BNC). UUI was more common at 6 weeks in the SPG, and SUI was more common at 6 weeks in the LPG, but no difference was noted at the 4-month and 1-year time points. Pad use was equal between the two groups at all time points.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Plasmakinetic enucleation of the prostate provides an effective treatment option for prostates of all sizes; however, prostates &lt;75\u2009g have a higher rate of BNC and urethral strictures compared with those &gt;75\u2009g.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/end.2021.0911","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T08:16:49Z","timestamp":1641975409000},"page":"969-976","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Complications Based on Prostate Size After Plasmakinetic Enucleation of the Prostate"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-044X","authenticated-orcid":false,"given":"Abrar","family":"Mian","sequence":"first","affiliation":[{"name":"Midwestern University College of Osteopathic Medicine, Downers Grove, Illinois, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia L.","family":"Balzano","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pachorek","sequence":"additional","affiliation":[{"name":"Pasadena City College, Pasadena, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre-Philippe","family":"Sam","sequence":"additional","affiliation":[{"name":"University of California Riverside, Riverside, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora H.","family":"Ruel","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, City of Hope National Medical Center, Duarte, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N.","family":"Warner","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00966.x"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.05.048"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.06.017"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39047-X"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000019535"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.06.021"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.06.012"},{"key":"e_1_3_5_9_2","first-page":"1","article-title":"The complications of the HoLEP learning curve. A systematic review","volume":"44","author":"Agreda Castaneda F","year":"2020","unstructured":"Agreda Castaneda F, , Buisan Rueda O, , Areal Calama JJ. The complications of the HoLEP learning curve. A systematic review. Actas Urol Esp (Engl Ed), 2020; 44:1\u20138.","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2011.0059"},{"issue":"3","key":"e_1_3_5_11_2","first-page":"44","article-title":"Holmium laser enucleation of the prostate (HoLEP): Size-independent gold standard for surgical management of benign prostatic hyperplasia","volume":"27","author":"Das AK","year":"2020","unstructured":"Das AK, , Han TM, , Hardacker TJ. Holmium laser enucleation of the prostate (HoLEP): Size-independent gold standard for surgical management of benign prostatic hyperplasia. Can J Urol, 2020; 27(S3):44\u201350.","journal-title":"Can J Urol"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1735-9"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03382-x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2021.0086"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02890-9"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/and.13631"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.17011"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.11.034"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.09.035"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.07.010"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2494-1"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0187-5"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.02.035"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2006.0123"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.juro.2012.11.027","article-title":"Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia","volume":"189","author":"Krambeck AE","year":"2013","unstructured":"Krambeck AE, , Handa SE, , Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol, 2013; 189(1 Suppl):S141\u2013S145.","journal-title":"J Urol"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12831"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13472"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000280"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000357626"}],"container-title":["Journal of Endourology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/end.2021.0911","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2021.0911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2021.0911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:14:22Z","timestamp":1777407262000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/end.2021.0911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1089\/end.2021.0911"],"URL":"https:\/\/doi.org\/10.1089\/end.2021.0911","relation":{},"ISSN":["0892-7790","1557-900X"],"issn-type":[{"value":"0892-7790","type":"print"},{"value":"1557-900X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}